Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/7CI stock hub

FRA/7CI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/7CIis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
810.3M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/7CIFRA/7CI
—
Loading chart…
In the news

Latest news · FRA/7CI

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-0.3
P25 n/aP50 n/aP75 n/a
ROIC-5.5
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/7CI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
171
Groups with data
11
Currency
USD
Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
Canada
Country code
DE
Employees
610
Employees Change
103%
Employees Change Percent
28.93
Enterprise value
EUR 145.5M
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 810.3M
Price
EUR 2.15
Price currency
EUR
Rev Per Employee
204,669.1x
Sic
2834
Symbol
fra/7CI
Website
https://thecronosgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-0.99%
EV Earnings
-18.09x
EV/FCF
1,146.91x
EV/Sales
1.17x
FCF yield
0.02%
P/B ratio
0.83x
P/S ratio
6.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

18
MetricValue
EBIT Margin
-11.61%
EBITDA Margin
-2.29%
FCF margin
0.1%
Gross margin
39.84%
Gross Profit
EUR 49.7M
Gross Profit Growth
91.59%
Gross Profit Growth Q
79.22%
Gross Profit Growth3 Y
55.82%
Net Income
EUR -8M
Pretax Margin
-11.68%
Profit Margin
-6.44%
Profit Per Employee
EUR -13,190
ROA
-0.9
Roa5y
-3.85
ROCE
-1.48
ROE
-0.26
Roe5y
-4.78
ROIC
-5.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
37.37%
Cagr3y
6.54%
Cagr5y
-19.66%
FCF Growth
-97.68%
FCF Growth Q
132.13%
OCF Growth
37.27%
OCF Growth Q
53.3%
Revenue Growth
24.63x
Revenue Growth Q
46.96x
Revenue Growth3 Y
19.11x
Revenue Growth5 Y
25.7x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
EUR 0.12
Assets
EUR 1B
Cash
EUR 708.4M
Current Assets
EUR 800.5M
Current Liabilities
EUR 40.9M
Debt
EUR 1.3M
Debt Equity
EUR 0
Debt FCF
EUR 10.13
Equity
EUR 973.5M
Liabilities
EUR 46.1M
Long Term Assets
EUR 219.1M
Long Term Liabilities
EUR 5.3M
Net Cash
EUR 707.2M
Net Cash By Market Cap
EUR 87.27
Net Cash Growth
-3.09%
Net Debt Equity
EUR -0.73
Net Debt FCF
EUR -5,572
Tangible Book Value
EUR 867.5M
Tangible Book Value Per Share
EUR 2.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
19.59
Inventory Turnover
2.21
Net Working Capital
EUR 54.9M
Quick ratio
18.45
Working Capital
EUR 763M
Working Capital Turnover
EUR 0.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
37.34%
200-day SMA
2.16
3Y total return
20.95%
50-day SMA
2.19
50-day SMA vs 200-day SMA
50over200
5Y total return
-66.53%
All Time High
22.04
All Time High Change
-90.25%
All Time High Date
2019-02-04
All Time Low
1.07
All Time Low Change
101.5%
All Time Low Date
2017-06-08
ATR
0.05
Ch YTD
-3.68
High
2.15
High52
3.06
High52 Date
2025-12-15
High52ch
-29.76%
Low
2.15
Low52
1.57
Low52 Date
2025-06-23
Low52ch
37.34%
Ma50ch
-1.87%
Price vs 200-day SMA
-0.74%
RSI
45.11
RSI Monthly
50.27
RSI Weekly
49.46
Sharpe ratio
0.57x
Sortino ratio
1.18
Total Return
0.54%
Tr YTD
-3.68
Tr1m
-2.1%
Tr1w
-4.96%
Tr3m
0.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -14.5M
Operating margin
-11.61

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
194,910,022%
Shares Insiders
6.59%
Shares Institutions
15.08%
Shares Qo Q
-0.64%
Shares Yo Y
-0.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Adjusted FCF
EUR -5.9M
Average Volume
91.75x
Bv Per Share
2.44
CAPEX
EUR -21.9M
Ch1m
-2.1
Ch1w
-4.96
Ch1y
37.34
Ch3m
0.75
Ch3y
20.95
Ch5y
-66.53
Ch6m
2.29
Change
-2.01%
Change From Open
0
Close
2.19
Days Gap
-2.01
Depreciation Amortization
11,584,856.8
Earnings Date
2026-05-11
EBIT
EUR -14.5M
EBITDA
EUR -2.9M
EPS
EUR -0.02
F Score
5
FCF
EUR 126,903
FCF EV Yield
0.09x
Financing CF
-16,953,089
Fiscal Year End
December
Goodwill
56,370,817.8
Income Tax
EUR -12.1M
Investing CF
-65,205,300
Is Primary Listing
0
Last Earnings Date
2026-02-27
Last Report Date
2025-12-31
Ma150
2.2
Ma150ch
-2.19%
Ma20
2.22
Ma20ch
-3.33%
Net CF
-57,073,269
Next Earnings Date
2026-05-11
Open
2.15
P FCF Ratio
6,385.5
P OCF Ratio
36.78
Ppne
124,893,779.1
Price Date
2026-05-08
Ptbv Ratio
0.93
Relative Volume
0.09x
Revenue
124,848,148x
SBC By Revenue
4.81x
Share Based Comp
6,004,485
Tax By Revenue
-9.68x
Tr6m
2.29%
Z Score
10.8
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/7CI pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/7CI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+37.3%
S&P 500 1Y: n/a
3Y total return
+20.9%
S&P 500 3Y: n/a
5Y total return
-66.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/7CI?

Insider, institutional, and short-interest positioning.

Institutional ownership
+15.1%
Share of float held by funds and institutions
Insider ownership
+6.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.5%
Negative means the company is buying back shares.
Technical

FRA/7CI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
45.1
Neutral momentum band
Price vs 200-day MA
-0.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.57
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/7CI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/7CI stock rating?

fra/7CI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/7CI analysis?

The full report lives at /stocks/fra/7CI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/7CI?

The latest report frames fra/7CI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/7CI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.